Publications

2015

Sinnott JA, Rider JR, Carlsson J, Gerke T, Tyekucheva S, Penney KL, et al. Molecular differences in transition zone and peripheral zone prostate tumors. Carcinogenesis. 2015;36(6):632-8.
Westblade LF, Fischer PU, Haghi N, Schniederjan MJ, Pritt BS, Long JG, et al. A five-year-old child with a subcutaneous forehead nodule. Pediatr Dev Pathol. 2015;18(2):164-6.
Young LM, Marzio A, Perez-Duran P, Reid DA, Meredith DN, Roberti D, et al. TIMELESS Forms a Complex with PARP1 Distinct from Its Complex with TIPIN and Plays a Role in the DNA Damage Response. Cell Rep. 2015;13(3):451-459.
Yang C, Boyson CA, Di Liberto M, Huang X, Hannah J, Dorn DC, et al. CDK4/6 Inhibitor PD 0332991 Sensitizes Acute Myeloid Leukemia to Cytarabine-Mediated Cytotoxicity. Cancer Res. 2015;75(9):1838-45.
Baumann C, Lamesic G, Weiss M, Cushing MM, Haas T. Evaluation of the minimum volume of salvage blood required for the successful use of two different autotransfusion devices. Paediatr Anaesth. 2015;25(3):258-64.
Rodrigues LU, Rider L, Nieto C, Romero L, Karimpour-Fard A, Loda M, et al. Coordinate loss of MAP3K7 and CHD1 promotes aggressive prostate cancer. Cancer Res. 2015;75(6):1021-34.
Pan H, Jiang Y, Boi M, Tabbo F, Redmond D, Nie K, et al. Epigenomic evolution in diffuse large B-cell lymphomas. Nat Commun. 2015;6:6921.
Baras AS, Gandhi N, Munari E, Faraj S, Shultz L, Marchionni L, et al. Identification and Validation of Protein Biomarkers of Response to Neoadjuvant Platinum Chemotherapy in Muscle Invasive Urothelial Carcinoma. PLoS One. 2015;10(7):e0131245.

Pathology & Laboratory Medicine 1300 York Avenue New York, NY 10065 Phone: (212) 746-6464
Surgical Pathology: (212) 746-2700